| Paul Rollins, MD | |
|
290 Haida Ave, Hastings, PA 16646-5610 | |
| (814) 247-3100 | |
| Not Available |
| Full Name | Paul Rollins |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 10 Years |
| Location | 290 Haida Ave, Hastings, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942655493 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hudson Regional Hospital | Secaucus, NJ | Hospital |
| Chan Soon- Shiong Medical Center At Windber | Windber, PA | Hospital |
| Nason Medical Center, Llc | Roaring spring, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nason Physician Practices Llc | 5890012728 | 22 |
| Rite Medical Care Pc | 1153743307 | 17 |
| Stadium Emergency Associates | 6406150010 | 17 |
News Archive
Findings from a study that looked at susceptibility trends of Staphylococcus aureus in U.S. hospital patients showed that key antibiotics used to treat the bacteria became more active over the course of the study, a rare occurrence.
Many changes in the way America's doctors deliver care are challenging long-held notions of how health care functions for patients.
Medical device developers, Crospon, based in Ireland and Smart Medical Systems based in Ra'anana, Israel today announced that they have signed a collaborative agreement whereby Smart Medical will produce a custom version of their NaviAid™ external channel endoscope accessory for Crospon, to permit deployment and positioning of Crospon's EndoFLIP™ imaging catheter.
The National Cancer Institute awarded Chrysalis BioTherapeutics a $1.5 million contract to continue development of Chrysalin® to mitigate radiotherapy-induced damage to normal brain tissue. The project is a collaboration between Chrysalis, Baylor College of Medicine, and the University of Texas Medical Branch (UTMB).
OncoSec Medical Incorporated, which is developing its advanced-stage ElectroOncology therapies to treat solid tumor cancers, announced today that additional evaluation of a previous Phase I trial provided further evidence that a DNA plasmid encoded to produce IL-12 delivered by electroporation into melanoma lesions induces responses to known and novel antigens, resulting in regression of local treated lesions as well as distant untreated lesions.
› Verified 2 days ago
| Entity Name | Dlp Conemaugh Physician Practices Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932515905 PECOS PAC ID: 7315166949 Enrollment ID: O20140915002522 |
News Archive
Findings from a study that looked at susceptibility trends of Staphylococcus aureus in U.S. hospital patients showed that key antibiotics used to treat the bacteria became more active over the course of the study, a rare occurrence.
Many changes in the way America's doctors deliver care are challenging long-held notions of how health care functions for patients.
Medical device developers, Crospon, based in Ireland and Smart Medical Systems based in Ra'anana, Israel today announced that they have signed a collaborative agreement whereby Smart Medical will produce a custom version of their NaviAid™ external channel endoscope accessory for Crospon, to permit deployment and positioning of Crospon's EndoFLIP™ imaging catheter.
The National Cancer Institute awarded Chrysalis BioTherapeutics a $1.5 million contract to continue development of Chrysalin® to mitigate radiotherapy-induced damage to normal brain tissue. The project is a collaboration between Chrysalis, Baylor College of Medicine, and the University of Texas Medical Branch (UTMB).
OncoSec Medical Incorporated, which is developing its advanced-stage ElectroOncology therapies to treat solid tumor cancers, announced today that additional evaluation of a previous Phase I trial provided further evidence that a DNA plasmid encoded to produce IL-12 delivered by electroporation into melanoma lesions induces responses to known and novel antigens, resulting in regression of local treated lesions as well as distant untreated lesions.
› Verified 2 days ago
| Entity Name | Dlp Conemaugh Miners Medical Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629471768 PECOS PAC ID: 2860612439 Enrollment ID: O20141030001653 |
News Archive
Findings from a study that looked at susceptibility trends of Staphylococcus aureus in U.S. hospital patients showed that key antibiotics used to treat the bacteria became more active over the course of the study, a rare occurrence.
Many changes in the way America's doctors deliver care are challenging long-held notions of how health care functions for patients.
Medical device developers, Crospon, based in Ireland and Smart Medical Systems based in Ra'anana, Israel today announced that they have signed a collaborative agreement whereby Smart Medical will produce a custom version of their NaviAid™ external channel endoscope accessory for Crospon, to permit deployment and positioning of Crospon's EndoFLIP™ imaging catheter.
The National Cancer Institute awarded Chrysalis BioTherapeutics a $1.5 million contract to continue development of Chrysalin® to mitigate radiotherapy-induced damage to normal brain tissue. The project is a collaboration between Chrysalis, Baylor College of Medicine, and the University of Texas Medical Branch (UTMB).
OncoSec Medical Incorporated, which is developing its advanced-stage ElectroOncology therapies to treat solid tumor cancers, announced today that additional evaluation of a previous Phase I trial provided further evidence that a DNA plasmid encoded to produce IL-12 delivered by electroporation into melanoma lesions induces responses to known and novel antigens, resulting in regression of local treated lesions as well as distant untreated lesions.
› Verified 2 days ago
| Entity Name | Nason Physician Practices Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306236609 PECOS PAC ID: 5890012728 Enrollment ID: O20150402000491 |
News Archive
Findings from a study that looked at susceptibility trends of Staphylococcus aureus in U.S. hospital patients showed that key antibiotics used to treat the bacteria became more active over the course of the study, a rare occurrence.
Many changes in the way America's doctors deliver care are challenging long-held notions of how health care functions for patients.
Medical device developers, Crospon, based in Ireland and Smart Medical Systems based in Ra'anana, Israel today announced that they have signed a collaborative agreement whereby Smart Medical will produce a custom version of their NaviAid™ external channel endoscope accessory for Crospon, to permit deployment and positioning of Crospon's EndoFLIP™ imaging catheter.
The National Cancer Institute awarded Chrysalis BioTherapeutics a $1.5 million contract to continue development of Chrysalin® to mitigate radiotherapy-induced damage to normal brain tissue. The project is a collaboration between Chrysalis, Baylor College of Medicine, and the University of Texas Medical Branch (UTMB).
OncoSec Medical Incorporated, which is developing its advanced-stage ElectroOncology therapies to treat solid tumor cancers, announced today that additional evaluation of a previous Phase I trial provided further evidence that a DNA plasmid encoded to produce IL-12 delivered by electroporation into melanoma lesions induces responses to known and novel antigens, resulting in regression of local treated lesions as well as distant untreated lesions.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Paul Rollins, MD 20 York Street, Cb-2041, New Haven, CT 06510-3220 Ph: (203) 688-1734 | Paul Rollins, MD 290 Haida Ave, Hastings, PA 16646-5610 Ph: (814) 247-3100 |
News Archive
Findings from a study that looked at susceptibility trends of Staphylococcus aureus in U.S. hospital patients showed that key antibiotics used to treat the bacteria became more active over the course of the study, a rare occurrence.
Many changes in the way America's doctors deliver care are challenging long-held notions of how health care functions for patients.
Medical device developers, Crospon, based in Ireland and Smart Medical Systems based in Ra'anana, Israel today announced that they have signed a collaborative agreement whereby Smart Medical will produce a custom version of their NaviAid™ external channel endoscope accessory for Crospon, to permit deployment and positioning of Crospon's EndoFLIP™ imaging catheter.
The National Cancer Institute awarded Chrysalis BioTherapeutics a $1.5 million contract to continue development of Chrysalin® to mitigate radiotherapy-induced damage to normal brain tissue. The project is a collaboration between Chrysalis, Baylor College of Medicine, and the University of Texas Medical Branch (UTMB).
OncoSec Medical Incorporated, which is developing its advanced-stage ElectroOncology therapies to treat solid tumor cancers, announced today that additional evaluation of a previous Phase I trial provided further evidence that a DNA plasmid encoded to produce IL-12 delivered by electroporation into melanoma lesions induces responses to known and novel antigens, resulting in regression of local treated lesions as well as distant untreated lesions.
› Verified 2 days ago
Samuel E Long, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 290 Haida Ave, Miners Hospital Emergency Physicians Group, Hastings, PA 16646 Phone: 814-247-3100 | |
Mr. Philip Siva Vittozzi Wong, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 290 Haida Ave, Hastings, PA 16646 Phone: 814-247-3100 | |
David G Hershberger, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 290 Haida Ave, Miners Hospital Emergency Physicians Group, Hastings, PA 16646 Phone: 814-247-3100 |